ACB
Aurora Cannabis Inc. Common Shares
Medicinal Chemicals & Botanical Products
Best Pharmaceutical Stocks 2026 →
ACB Stock Analysis: Buy, Sell, or Hold?
$4.94
-0.05 (-1.00%)
▼
5d:
-5.73%
30d:
+20.49%
90d:
+37.22%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
0d
Protect ACB Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (29%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$3.98 – $4.93
Position: EXTENDED
Forward P/E & Valuation
-823.3x
CHEAP
vs 43.0x historical avg
Wall Street Target
$6.23
+26.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.09 / $5.30
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ACB shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACB is currently trading at $4.94, which is considered extended relative to its 30-day fair value range of $3.98 to $4.93. From a valuation perspective, the stock is trading at a discount (Forward PE: -823.3) compared to its historical average (43.0). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ACB is in a strong uptrend. Immediate support is located at $4.09, while resistance sits at $5.30.
Market Sentiment: ACB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.23 (+26.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACB is in a strong uptrend. Immediate support is located at $4.09, while resistance sits at $5.30.
Market Sentiment: ACB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.23 (+26.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.98 -
$4.93
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
28.6%
Trading Range & Key Levels
30-Day Trading Range
$3.98 -
$4.93
Current vs Trading Range
EXTENDED
Support Level
$4.09
Resistance Level
$5.30
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding ACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.0% below Wall St target ($6.23)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-823.33
Wall Street Target
$6.23
(+26.0%)
Revenue Growth (YoY)
-8.8%
Earnings Growth (YoY)
-94.7%
Profit Margin
-38.2%
PE vs Historical
-823.3 vs 43.0
CHEAP
Share ACB Analysis
Share this live ACB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACB)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages express bullish sentiment towards $ACB, highlighting its large presence in Texas and absence of debt. The latest Yahoo Finance news reports Organigram's CEO expressing confidence in facing Curaleaf's bid for Aurora Cannabis.
Key Retail Themes:
Company size and presence in Texas
Absence of debt
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 6:39 AM ET
Data refreshes hourly during market hours. Next update: 7:39 AM
Data refreshes hourly during market hours. Next update: 7:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 30 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 39 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 47 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
Advanced ACB Option Strategies
Professional options setups generated by AI based on today's ACB price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACB Research Pages
